nodes	percent_of_prediction	percent_of_DWPC	metapath
Codeine—UGT2B7—Epirubicin—liver cancer	0.329	0.451	CbGbCtD
Codeine—CYP3A7—Sorafenib—liver cancer	0.101	0.139	CbGbCtD
Codeine—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.101	0.139	CbGbCtD
Codeine—CYP3A5—Sorafenib—liver cancer	0.0759	0.104	CbGbCtD
Codeine—CYP2D6—Sorafenib—liver cancer	0.0466	0.0638	CbGbCtD
Codeine—CYP3A4—Sorafenib—liver cancer	0.0296	0.0406	CbGbCtD
Codeine—CYP2D6—Doxorubicin—liver cancer	0.0282	0.0387	CbGbCtD
Codeine—CYP3A4—Doxorubicin—liver cancer	0.018	0.0246	CbGbCtD
Codeine—Rhinorrhoea—Sorafenib—liver cancer	0.00263	0.0298	CcSEcCtD
Codeine—Bone disorder—Sorafenib—liver cancer	0.00236	0.0267	CcSEcCtD
Codeine—Mood swings—Sorafenib—liver cancer	0.00146	0.0166	CcSEcCtD
Codeine—Dehydration—Sorafenib—liver cancer	0.00144	0.0163	CcSEcCtD
Codeine—Hypothermia—Epirubicin—liver cancer	0.0014	0.0159	CcSEcCtD
Codeine—Body temperature decreased—Epirubicin—liver cancer	0.0014	0.0159	CcSEcCtD
Codeine—Breast disorder—Sorafenib—liver cancer	0.0014	0.0158	CcSEcCtD
Codeine—Nasopharyngitis—Sorafenib—liver cancer	0.00138	0.0156	CcSEcCtD
Codeine—Lacrimation—Epirubicin—liver cancer	0.00134	0.0152	CcSEcCtD
Codeine—Pancreatitis—Sorafenib—liver cancer	0.00131	0.0148	CcSEcCtD
Codeine—Body temperature decreased—Doxorubicin—liver cancer	0.0013	0.0147	CcSEcCtD
Codeine—Hypothermia—Doxorubicin—liver cancer	0.0013	0.0147	CcSEcCtD
Codeine—Abdominal discomfort—Sorafenib—liver cancer	0.00128	0.0145	CcSEcCtD
Codeine—Lacrimation—Doxorubicin—liver cancer	0.00124	0.014	CcSEcCtD
Codeine—Redness—Epirubicin—liver cancer	0.00116	0.0132	CcSEcCtD
Codeine—Redness—Doxorubicin—liver cancer	0.00108	0.0122	CcSEcCtD
Codeine—Urinary tract disorder—Sorafenib—liver cancer	0.00106	0.012	CcSEcCtD
Codeine—Urethral disorder—Sorafenib—liver cancer	0.00105	0.0119	CcSEcCtD
Codeine—Flushing—Sorafenib—liver cancer	0.000992	0.0112	CcSEcCtD
Codeine—Cardiac disorder—Sorafenib—liver cancer	0.000992	0.0112	CcSEcCtD
Codeine—Immune system disorder—Sorafenib—liver cancer	0.000965	0.0109	CcSEcCtD
Codeine—Mediastinal disorder—Sorafenib—liver cancer	0.000963	0.0109	CcSEcCtD
Codeine—Erythema—Sorafenib—liver cancer	0.00093	0.0105	CcSEcCtD
Codeine—Muscle spasms—Sorafenib—liver cancer	0.000894	0.0101	CcSEcCtD
Codeine—Bone disorder—Epirubicin—liver cancer	0.000871	0.00986	CcSEcCtD
Codeine—Lacrimation increased—Epirubicin—liver cancer	0.000853	0.00967	CcSEcCtD
Codeine—Angioedema—Sorafenib—liver cancer	0.00085	0.00963	CcSEcCtD
Codeine—Syncope—Sorafenib—liver cancer	0.000834	0.00945	CcSEcCtD
Codeine—Loss of consciousness—Sorafenib—liver cancer	0.000818	0.00926	CcSEcCtD
Codeine—Bone disorder—Doxorubicin—liver cancer	0.000806	0.00913	CcSEcCtD
Codeine—Lacrimation increased—Doxorubicin—liver cancer	0.00079	0.00895	CcSEcCtD
Codeine—Dry mouth—Sorafenib—liver cancer	0.000775	0.00878	CcSEcCtD
Codeine—Shock—Sorafenib—liver cancer	0.000747	0.00846	CcSEcCtD
Codeine—Nervous system disorder—Sorafenib—liver cancer	0.000745	0.00844	CcSEcCtD
Codeine—Anorexia—Sorafenib—liver cancer	0.000724	0.0082	CcSEcCtD
Codeine—Dyspnoea—Sorafenib—liver cancer	0.000677	0.00767	CcSEcCtD
Codeine—Decreased appetite—Sorafenib—liver cancer	0.00066	0.00748	CcSEcCtD
Codeine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000655	0.00743	CcSEcCtD
Codeine—Fatigue—Sorafenib—liver cancer	0.000655	0.00742	CcSEcCtD
Codeine—Constipation—Sorafenib—liver cancer	0.000649	0.00736	CcSEcCtD
Codeine—Gastrointestinal pain—Sorafenib—liver cancer	0.000621	0.00703	CcSEcCtD
Codeine—Urticaria—Sorafenib—liver cancer	0.000603	0.00683	CcSEcCtD
Codeine—Body temperature increased—Sorafenib—liver cancer	0.0006	0.0068	CcSEcCtD
Codeine—Abdominal pain—Sorafenib—liver cancer	0.0006	0.0068	CcSEcCtD
Codeine—Diplopia—Epirubicin—liver cancer	0.000571	0.00647	CcSEcCtD
Codeine—Affect lability—Epirubicin—liver cancer	0.000562	0.00637	CcSEcCtD
Codeine—Hypersensitivity—Sorafenib—liver cancer	0.000559	0.00634	CcSEcCtD
Codeine—Asthenia—Sorafenib—liver cancer	0.000545	0.00617	CcSEcCtD
Codeine—Cardiac arrest—Epirubicin—liver cancer	0.000543	0.00615	CcSEcCtD
Codeine—Mood swings—Epirubicin—liver cancer	0.000541	0.00613	CcSEcCtD
Codeine—Pruritus—Sorafenib—liver cancer	0.000537	0.00609	CcSEcCtD
Codeine—Dehydration—Epirubicin—liver cancer	0.000531	0.00601	CcSEcCtD
Codeine—Diplopia—Doxorubicin—liver cancer	0.000528	0.00598	CcSEcCtD
Codeine—Orthostatic hypotension—Epirubicin—liver cancer	0.000521	0.00591	CcSEcCtD
Codeine—Affect lability—Doxorubicin—liver cancer	0.00052	0.00589	CcSEcCtD
Codeine—Breast disorder—Epirubicin—liver cancer	0.000516	0.00584	CcSEcCtD
Codeine—Nasopharyngitis—Epirubicin—liver cancer	0.00051	0.00578	CcSEcCtD
Codeine—Cardiac arrest—Doxorubicin—liver cancer	0.000502	0.00569	CcSEcCtD
Codeine—Dizziness—Sorafenib—liver cancer	0.000502	0.00569	CcSEcCtD
Codeine—Mood swings—Doxorubicin—liver cancer	0.0005	0.00567	CcSEcCtD
Codeine—Dehydration—Doxorubicin—liver cancer	0.000491	0.00557	CcSEcCtD
Codeine—Pancreatitis—Epirubicin—liver cancer	0.000484	0.00548	CcSEcCtD
Codeine—Vomiting—Sorafenib—liver cancer	0.000483	0.00547	CcSEcCtD
Codeine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000482	0.00547	CcSEcCtD
Codeine—Rash—Sorafenib—liver cancer	0.000479	0.00542	CcSEcCtD
Codeine—Dermatitis—Sorafenib—liver cancer	0.000478	0.00542	CcSEcCtD
Codeine—Breast disorder—Doxorubicin—liver cancer	0.000477	0.00541	CcSEcCtD
Codeine—Nasopharyngitis—Doxorubicin—liver cancer	0.000472	0.00535	CcSEcCtD
Codeine—Nausea—Sorafenib—liver cancer	0.000451	0.00511	CcSEcCtD
Codeine—Pancreatitis—Doxorubicin—liver cancer	0.000448	0.00507	CcSEcCtD
Codeine—Drowsiness—Epirubicin—liver cancer	0.00044	0.00498	CcSEcCtD
Codeine—Sweating—Epirubicin—liver cancer	0.000422	0.00478	CcSEcCtD
Codeine—Drowsiness—Doxorubicin—liver cancer	0.000407	0.00461	CcSEcCtD
Codeine—Bradycardia—Epirubicin—liver cancer	0.000402	0.00455	CcSEcCtD
Codeine—Sweating—Doxorubicin—liver cancer	0.00039	0.00442	CcSEcCtD
Codeine—Urinary tract disorder—Epirubicin—liver cancer	0.00039	0.00442	CcSEcCtD
Codeine—Urethral disorder—Epirubicin—liver cancer	0.000387	0.00439	CcSEcCtD
Codeine—Visual impairment—Epirubicin—liver cancer	0.000381	0.00431	CcSEcCtD
Codeine—Bradycardia—Doxorubicin—liver cancer	0.000372	0.00421	CcSEcCtD
Codeine—Eye disorder—Epirubicin—liver cancer	0.000369	0.00418	CcSEcCtD
Codeine—Cardiac disorder—Epirubicin—liver cancer	0.000367	0.00415	CcSEcCtD
Codeine—Flushing—Epirubicin—liver cancer	0.000367	0.00415	CcSEcCtD
Codeine—Urinary tract disorder—Doxorubicin—liver cancer	0.000361	0.00409	CcSEcCtD
Codeine—Urethral disorder—Doxorubicin—liver cancer	0.000358	0.00406	CcSEcCtD
Codeine—Immune system disorder—Epirubicin—liver cancer	0.000357	0.00404	CcSEcCtD
Codeine—Mediastinal disorder—Epirubicin—liver cancer	0.000356	0.00403	CcSEcCtD
Codeine—Visual impairment—Doxorubicin—liver cancer	0.000352	0.00399	CcSEcCtD
Codeine—Erythema—Epirubicin—liver cancer	0.000344	0.00389	CcSEcCtD
Codeine—Eye disorder—Doxorubicin—liver cancer	0.000342	0.00387	CcSEcCtD
Codeine—Cardiac disorder—Doxorubicin—liver cancer	0.000339	0.00384	CcSEcCtD
Codeine—Flushing—Doxorubicin—liver cancer	0.000339	0.00384	CcSEcCtD
Codeine—Tension—Epirubicin—liver cancer	0.000337	0.00382	CcSEcCtD
Codeine—Nervousness—Epirubicin—liver cancer	0.000334	0.00378	CcSEcCtD
Codeine—Muscle spasms—Epirubicin—liver cancer	0.000331	0.00374	CcSEcCtD
Codeine—Immune system disorder—Doxorubicin—liver cancer	0.00033	0.00374	CcSEcCtD
Codeine—Mediastinal disorder—Doxorubicin—liver cancer	0.000329	0.00373	CcSEcCtD
Codeine—Ill-defined disorder—Epirubicin—liver cancer	0.000319	0.00361	CcSEcCtD
Codeine—Erythema—Doxorubicin—liver cancer	0.000318	0.0036	CcSEcCtD
Codeine—Agitation—Epirubicin—liver cancer	0.000316	0.00358	CcSEcCtD
Codeine—Tension—Doxorubicin—liver cancer	0.000312	0.00354	CcSEcCtD
Codeine—Malaise—Epirubicin—liver cancer	0.00031	0.00351	CcSEcCtD
Codeine—Nervousness—Doxorubicin—liver cancer	0.000309	0.0035	CcSEcCtD
Codeine—Vertigo—Epirubicin—liver cancer	0.000309	0.0035	CcSEcCtD
Codeine—Syncope—Epirubicin—liver cancer	0.000308	0.00349	CcSEcCtD
Codeine—Muscle spasms—Doxorubicin—liver cancer	0.000306	0.00346	CcSEcCtD
Codeine—Palpitations—Epirubicin—liver cancer	0.000304	0.00344	CcSEcCtD
Codeine—Loss of consciousness—Epirubicin—liver cancer	0.000302	0.00342	CcSEcCtD
Codeine—Convulsion—Epirubicin—liver cancer	0.000298	0.00337	CcSEcCtD
Codeine—Ill-defined disorder—Doxorubicin—liver cancer	0.000295	0.00334	CcSEcCtD
Codeine—Agitation—Doxorubicin—liver cancer	0.000292	0.00331	CcSEcCtD
Codeine—Anxiety—Epirubicin—liver cancer	0.000292	0.0033	CcSEcCtD
Codeine—Discomfort—Epirubicin—liver cancer	0.000289	0.00328	CcSEcCtD
Codeine—Malaise—Doxorubicin—liver cancer	0.000287	0.00325	CcSEcCtD
Codeine—Dry mouth—Epirubicin—liver cancer	0.000286	0.00324	CcSEcCtD
Codeine—Vertigo—Doxorubicin—liver cancer	0.000286	0.00324	CcSEcCtD
Codeine—Syncope—Doxorubicin—liver cancer	0.000285	0.00323	CcSEcCtD
Codeine—Confusional state—Epirubicin—liver cancer	0.000283	0.00321	CcSEcCtD
Codeine—Palpitations—Doxorubicin—liver cancer	0.000281	0.00318	CcSEcCtD
Codeine—Loss of consciousness—Doxorubicin—liver cancer	0.00028	0.00317	CcSEcCtD
Codeine—Shock—Epirubicin—liver cancer	0.000276	0.00313	CcSEcCtD
Codeine—Convulsion—Doxorubicin—liver cancer	0.000276	0.00312	CcSEcCtD
Codeine—Nervous system disorder—Epirubicin—liver cancer	0.000275	0.00312	CcSEcCtD
Codeine—Tachycardia—Epirubicin—liver cancer	0.000274	0.0031	CcSEcCtD
Codeine—Hyperhidrosis—Epirubicin—liver cancer	0.000271	0.00307	CcSEcCtD
Codeine—Anxiety—Doxorubicin—liver cancer	0.00027	0.00306	CcSEcCtD
Codeine—Discomfort—Doxorubicin—liver cancer	0.000268	0.00303	CcSEcCtD
Codeine—Anorexia—Epirubicin—liver cancer	0.000267	0.00303	CcSEcCtD
Codeine—Dry mouth—Doxorubicin—liver cancer	0.000265	0.003	CcSEcCtD
Codeine—Hypotension—Epirubicin—liver cancer	0.000262	0.00297	CcSEcCtD
Codeine—Confusional state—Doxorubicin—liver cancer	0.000262	0.00297	CcSEcCtD
Codeine—Shock—Doxorubicin—liver cancer	0.000255	0.00289	CcSEcCtD
Codeine—Nervous system disorder—Doxorubicin—liver cancer	0.000255	0.00288	CcSEcCtD
Codeine—Insomnia—Epirubicin—liver cancer	0.000254	0.00288	CcSEcCtD
Codeine—Tachycardia—Doxorubicin—liver cancer	0.000253	0.00287	CcSEcCtD
Codeine—Hyperhidrosis—Doxorubicin—liver cancer	0.000251	0.00284	CcSEcCtD
Codeine—Dyspnoea—Epirubicin—liver cancer	0.00025	0.00283	CcSEcCtD
Codeine—Somnolence—Epirubicin—liver cancer	0.000249	0.00283	CcSEcCtD
Codeine—Anorexia—Doxorubicin—liver cancer	0.000247	0.0028	CcSEcCtD
Codeine—Decreased appetite—Epirubicin—liver cancer	0.000244	0.00276	CcSEcCtD
Codeine—Hypotension—Doxorubicin—liver cancer	0.000243	0.00275	CcSEcCtD
Codeine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000242	0.00274	CcSEcCtD
Codeine—Fatigue—Epirubicin—liver cancer	0.000242	0.00274	CcSEcCtD
Codeine—Constipation—Epirubicin—liver cancer	0.00024	0.00272	CcSEcCtD
Codeine—Insomnia—Doxorubicin—liver cancer	0.000235	0.00266	CcSEcCtD
Codeine—Dyspnoea—Doxorubicin—liver cancer	0.000231	0.00262	CcSEcCtD
Codeine—Feeling abnormal—Epirubicin—liver cancer	0.000231	0.00262	CcSEcCtD
Codeine—Somnolence—Doxorubicin—liver cancer	0.000231	0.00261	CcSEcCtD
Codeine—Gastrointestinal pain—Epirubicin—liver cancer	0.000229	0.0026	CcSEcCtD
Codeine—Decreased appetite—Doxorubicin—liver cancer	0.000226	0.00256	CcSEcCtD
Codeine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000224	0.00254	CcSEcCtD
Codeine—Fatigue—Doxorubicin—liver cancer	0.000224	0.00254	CcSEcCtD
Codeine—Urticaria—Epirubicin—liver cancer	0.000223	0.00253	CcSEcCtD
Codeine—Constipation—Doxorubicin—liver cancer	0.000222	0.00252	CcSEcCtD
Codeine—Body temperature increased—Epirubicin—liver cancer	0.000222	0.00251	CcSEcCtD
Codeine—Abdominal pain—Epirubicin—liver cancer	0.000222	0.00251	CcSEcCtD
Codeine—Feeling abnormal—Doxorubicin—liver cancer	0.000214	0.00242	CcSEcCtD
Codeine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000212	0.00241	CcSEcCtD
Codeine—Hypersensitivity—Epirubicin—liver cancer	0.000207	0.00234	CcSEcCtD
Codeine—Urticaria—Doxorubicin—liver cancer	0.000206	0.00234	CcSEcCtD
Codeine—Abdominal pain—Doxorubicin—liver cancer	0.000205	0.00233	CcSEcCtD
Codeine—Body temperature increased—Doxorubicin—liver cancer	0.000205	0.00233	CcSEcCtD
Codeine—Asthenia—Epirubicin—liver cancer	0.000201	0.00228	CcSEcCtD
Codeine—Pruritus—Epirubicin—liver cancer	0.000199	0.00225	CcSEcCtD
Codeine—Hypersensitivity—Doxorubicin—liver cancer	0.000191	0.00217	CcSEcCtD
Codeine—Asthenia—Doxorubicin—liver cancer	0.000186	0.00211	CcSEcCtD
Codeine—Dizziness—Epirubicin—liver cancer	0.000186	0.0021	CcSEcCtD
Codeine—Pruritus—Doxorubicin—liver cancer	0.000184	0.00208	CcSEcCtD
Codeine—Vomiting—Epirubicin—liver cancer	0.000178	0.00202	CcSEcCtD
Codeine—Rash—Epirubicin—liver cancer	0.000177	0.002	CcSEcCtD
Codeine—Dermatitis—Epirubicin—liver cancer	0.000177	0.002	CcSEcCtD
Codeine—Dizziness—Doxorubicin—liver cancer	0.000172	0.00194	CcSEcCtD
Codeine—Nausea—Epirubicin—liver cancer	0.000167	0.00189	CcSEcCtD
Codeine—Vomiting—Doxorubicin—liver cancer	0.000165	0.00187	CcSEcCtD
Codeine—Rash—Doxorubicin—liver cancer	0.000164	0.00185	CcSEcCtD
Codeine—Dermatitis—Doxorubicin—liver cancer	0.000164	0.00185	CcSEcCtD
Codeine—Nausea—Doxorubicin—liver cancer	0.000154	0.00175	CcSEcCtD
Codeine—SLC22A1—Transmembrane transport of small molecules—RAF1—liver cancer	2.94e-05	0.000162	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TERT—liver cancer	2.94e-05	0.000162	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—CYCS—liver cancer	2.92e-05	0.000161	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CSF2—liver cancer	2.89e-05	0.000159	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—RAF1—liver cancer	2.89e-05	0.000159	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—GOT1—liver cancer	2.87e-05	0.000158	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—GGT1—liver cancer	2.87e-05	0.000158	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—H2AFX—liver cancer	2.85e-05	0.000157	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—IL2—liver cancer	2.85e-05	0.000157	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GSTA4—liver cancer	2.85e-05	0.000156	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—PIK3CA—liver cancer	2.83e-05	0.000156	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—PIK3CB—liver cancer	2.82e-05	0.000155	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GSTA2—liver cancer	2.77e-05	0.000153	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—GSTP1—liver cancer	2.77e-05	0.000152	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—PRKCE—liver cancer	2.76e-05	0.000152	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PIK3CG—liver cancer	2.76e-05	0.000152	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—PIK3CD—liver cancer	2.73e-05	0.00015	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—HMOX1—liver cancer	2.73e-05	0.00015	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—KDR—liver cancer	2.69e-05	0.000148	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GSTA1—liver cancer	2.68e-05	0.000147	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—MAPK14—liver cancer	2.67e-05	0.000147	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PPARG—liver cancer	2.67e-05	0.000147	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PSMA4—liver cancer	2.65e-05	0.000146	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PSMD10—liver cancer	2.65e-05	0.000146	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—NAT2—liver cancer	2.65e-05	0.000145	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—PIK3CB—liver cancer	2.62e-05	0.000144	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—ESR1—liver cancer	2.62e-05	0.000144	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—IGF2—liver cancer	2.62e-05	0.000144	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—F2—liver cancer	2.59e-05	0.000142	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—IL2—liver cancer	2.59e-05	0.000142	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—GOT2—liver cancer	2.58e-05	0.000142	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TERT—liver cancer	2.58e-05	0.000142	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—GSTP1—liver cancer	2.57e-05	0.000142	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—GSTM1—liver cancer	2.54e-05	0.00014	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—HMOX1—liver cancer	2.54e-05	0.00014	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—ALDOB—liver cancer	2.54e-05	0.000139	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—APC—liver cancer	2.48e-05	0.000136	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—PIK3CG—liver cancer	2.48e-05	0.000136	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CSF2—liver cancer	2.44e-05	0.000134	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—RAF1—liver cancer	2.44e-05	0.000134	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PIK3CD—liver cancer	2.43e-05	0.000134	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—CYP2E1—liver cancer	2.43e-05	0.000133	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—CRABP1—liver cancer	2.42e-05	0.000133	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—CYP1A1—liver cancer	2.41e-05	0.000133	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—H2AFX—liver cancer	2.41e-05	0.000132	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—IL2—liver cancer	2.41e-05	0.000132	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—ALB—liver cancer	2.4e-05	0.000132	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—PIK3CB—liver cancer	2.38e-05	0.000131	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—GSTM1—liver cancer	2.37e-05	0.00013	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—KDR—liver cancer	2.36e-05	0.00013	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—MAPK14—liver cancer	2.34e-05	0.000129	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—BRAF—liver cancer	2.33e-05	0.000128	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—AKT1—liver cancer	2.31e-05	0.000127	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—ESR1—liver cancer	2.3e-05	0.000126	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—F2—liver cancer	2.27e-05	0.000125	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—CYCS—liver cancer	2.27e-05	0.000125	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—MTHFR—liver cancer	2.25e-05	0.000124	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—CYP1A1—liver cancer	2.24e-05	0.000123	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—GOT1—liver cancer	2.23e-05	0.000122	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—GGT1—liver cancer	2.23e-05	0.000122	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PPARA—liver cancer	2.2e-05	0.000121	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—IL2—liver cancer	2.19e-05	0.00012	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TERT—liver cancer	2.18e-05	0.00012	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—PIK3CD—liver cancer	2.18e-05	0.00012	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—APC—liver cancer	2.17e-05	0.000119	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—PIK3CG—liver cancer	2.17e-05	0.000119	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—PIK3CA—liver cancer	2.16e-05	0.000119	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—SERPINE1—liver cancer	2.15e-05	0.000118	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GLUL—liver cancer	2.15e-05	0.000118	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—CPT1B—liver cancer	2.15e-05	0.000118	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—KRAS—liver cancer	2.13e-05	0.000117	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PIK3CB—liver cancer	2.12e-05	0.000116	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—HPGDS—liver cancer	2.12e-05	0.000116	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—MTHFR—liver cancer	2.09e-05	0.000115	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—NR1H4—liver cancer	2.07e-05	0.000114	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PPARA—liver cancer	2.05e-05	0.000113	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—BRAF—liver cancer	2.04e-05	0.000112	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GSTA3—liver cancer	2.03e-05	0.000112	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—GSTP1—liver cancer	2e-05	0.00011	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—KDR—liver cancer	1.99e-05	0.00011	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—MAPK14—liver cancer	1.98e-05	0.000109	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—HMOX1—liver cancer	1.97e-05	0.000108	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—PIK3CA—liver cancer	1.96e-05	0.000108	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—RAF1—liver cancer	1.94e-05	0.000107	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—ESR1—liver cancer	1.94e-05	0.000107	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—F2—liver cancer	1.92e-05	0.000105	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—PIK3CD—liver cancer	1.91e-05	0.000105	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—MTOR—liver cancer	1.9e-05	0.000104	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—PIK3CB—liver cancer	1.9e-05	0.000104	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—PIK3CA—liver cancer	1.89e-05	0.000104	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—SERPINE1—liver cancer	1.89e-05	0.000104	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PIK3CG—liver cancer	1.89e-05	0.000104	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PSMA4—liver cancer	1.89e-05	0.000104	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PSMD10—liver cancer	1.89e-05	0.000104	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—KRAS—liver cancer	1.87e-05	0.000103	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GSTA4—liver cancer	1.86e-05	0.000102	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—GSTM1—liver cancer	1.84e-05	0.000101	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—PIK3CG—liver cancer	1.84e-05	0.000101	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—APC—liver cancer	1.84e-05	0.000101	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GOT2—liver cancer	1.83e-05	0.000101	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PPARG—liver cancer	1.82e-05	0.0001	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GSTA2—liver cancer	1.81e-05	9.97e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—HRAS—liver cancer	1.81e-05	9.96e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CDKN1B—liver cancer	1.78e-05	9.79e-05	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—AKT1—liver cancer	1.76e-05	9.69e-05	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PIK3CG—liver cancer	1.76e-05	9.66e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GSTA1—liver cancer	1.75e-05	9.62e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CASP3—liver cancer	1.75e-05	9.6e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—IL2—liver cancer	1.74e-05	9.58e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—CYP1A1—liver cancer	1.74e-05	9.58e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—IL6—liver cancer	1.73e-05	9.54e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—NAT2—liver cancer	1.73e-05	9.51e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—BRAF—liver cancer	1.73e-05	9.49e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—CYP2E1—liver cancer	1.72e-05	9.48e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—PIK3CA—liver cancer	1.72e-05	9.44e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—RAF1—liver cancer	1.7e-05	9.37e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CCND1—liver cancer	1.7e-05	9.34e-05	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PPARG—liver cancer	1.7e-05	9.32e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—JUN—liver cancer	1.7e-05	9.32e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CTNNB1—liver cancer	1.68e-05	9.25e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—PIK3CB—liver cancer	1.66e-05	9.15e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—MTOR—liver cancer	1.66e-05	9.15e-05	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PIK3CD—liver cancer	1.66e-05	9.13e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—ALDOB—liver cancer	1.66e-05	9.12e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—MMP9—liver cancer	1.65e-05	9.07e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CDKN1A—liver cancer	1.64e-05	9.04e-05	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—ALB—liver cancer	1.64e-05	9.01e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—MTHFR—liver cancer	1.62e-05	8.93e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—PIK3CD—liver cancer	1.61e-05	8.87e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—CYCS—liver cancer	1.61e-05	8.87e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—MAPK8—liver cancer	1.6e-05	8.82e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—AKT1—liver cancer	1.6e-05	8.8e-05	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—PIK3CA—liver cancer	1.6e-05	8.79e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—SERPINE1—liver cancer	1.6e-05	8.78e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PPARA—liver cancer	1.59e-05	8.76e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—HRAS—liver cancer	1.59e-05	8.74e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GGT1—liver cancer	1.58e-05	8.71e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GOT1—liver cancer	1.58e-05	8.71e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—CRABP1—liver cancer	1.58e-05	8.7e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—KRAS—liver cancer	1.58e-05	8.69e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CDKN1B—liver cancer	1.56e-05	8.59e-05	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—AKT1—liver cancer	1.54e-05	8.49e-05	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PIK3CD—liver cancer	1.54e-05	8.49e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CASP3—liver cancer	1.53e-05	8.42e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—IL2—liver cancer	1.53e-05	8.4e-05	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—ALB—liver cancer	1.52e-05	8.38e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—IL6—liver cancer	1.52e-05	8.36e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CCND1—liver cancer	1.49e-05	8.19e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—JUN—liver cancer	1.49e-05	8.17e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—VEGFA—liver cancer	1.48e-05	8.14e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CTNNB1—liver cancer	1.48e-05	8.11e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—STAT3—liver cancer	1.47e-05	8.06e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—PIK3CA—liver cancer	1.45e-05	7.98e-05	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PIK3CB—liver cancer	1.45e-05	7.95e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—MMP9—liver cancer	1.45e-05	7.95e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CDKN1A—liver cancer	1.44e-05	7.92e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—RAF1—liver cancer	1.44e-05	7.92e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GSTP1—liver cancer	1.42e-05	7.82e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—MAPK8—liver cancer	1.41e-05	7.73e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—MTOR—liver cancer	1.41e-05	7.73e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—PIK3CB—liver cancer	1.41e-05	7.73e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—AKT1—liver cancer	1.4e-05	7.71e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—HMOX1—liver cancer	1.4e-05	7.71e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—HPGDS—liver cancer	1.38e-05	7.6e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PIK3CG—liver cancer	1.36e-05	7.5e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—MYC—liver cancer	1.36e-05	7.49e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TGFB1—liver cancer	1.36e-05	7.48e-05	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PIK3CB—liver cancer	1.35e-05	7.4e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—HRAS—liver cancer	1.34e-05	7.38e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CDKN1B—liver cancer	1.32e-05	7.26e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PPARG—liver cancer	1.32e-05	7.24e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GSTM1—liver cancer	1.31e-05	7.19e-05	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—AKT1—liver cancer	1.31e-05	7.18e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—VEGFA—liver cancer	1.3e-05	7.14e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CASP3—liver cancer	1.29e-05	7.11e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—IL2—liver cancer	1.29e-05	7.1e-05	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PIK3CA—liver cancer	1.29e-05	7.09e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—STAT3—liver cancer	1.29e-05	7.07e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—IL6—liver cancer	1.29e-05	7.07e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—KRAS—liver cancer	1.26e-05	6.92e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CCND1—liver cancer	1.26e-05	6.92e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—JUN—liver cancer	1.26e-05	6.91e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CTNNB1—liver cancer	1.25e-05	6.86e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—CYP1A1—liver cancer	1.24e-05	6.81e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PSMA4—liver cancer	1.23e-05	6.78e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PSMD10—liver cancer	1.23e-05	6.78e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—MMP9—liver cancer	1.22e-05	6.72e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CDKN1A—liver cancer	1.22e-05	6.7e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PIK3CD—liver cancer	1.2e-05	6.6e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GOT2—liver cancer	1.2e-05	6.59e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—MYC—liver cancer	1.2e-05	6.57e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TGFB1—liver cancer	1.19e-05	6.55e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—MAPK8—liver cancer	1.19e-05	6.54e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—AKT1—liver cancer	1.19e-05	6.52e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—ALB—liver cancer	1.18e-05	6.51e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—PIK3CA—liver cancer	1.16e-05	6.36e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—MTHFR—liver cancer	1.15e-05	6.35e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PPARA—liver cancer	1.13e-05	6.23e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—CYP2E1—liver cancer	1.13e-05	6.2e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TP53—liver cancer	1.12e-05	6.15e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—KRAS—liver cancer	1.1e-05	6.07e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—VEGFA—liver cancer	1.1e-05	6.04e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—STAT3—liver cancer	1.09e-05	5.98e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—HRAS—liver cancer	1.07e-05	5.89e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—CYCS—liver cancer	1.05e-05	5.8e-05	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—AKT1—liver cancer	1.05e-05	5.8e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PIK3CB—liver cancer	1.05e-05	5.75e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GOT1—liver cancer	1.04e-05	5.69e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GGT1—liver cancer	1.04e-05	5.69e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—IL6—liver cancer	1.02e-05	5.63e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—PIK3CA—liver cancer	1.01e-05	5.58e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—MYC—liver cancer	1.01e-05	5.55e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TGFB1—liver cancer	1.01e-05	5.54e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TP53—liver cancer	9.81e-06	5.4e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PIK3CG—liver cancer	9.7e-06	5.34e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—AKT1—liver cancer	9.45e-06	5.2e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—HRAS—liver cancer	9.39e-06	5.16e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PPARG—liver cancer	9.37e-06	5.15e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—KRAS—liver cancer	9.33e-06	5.13e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GSTP1—liver cancer	9.3e-06	5.11e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—HMOX1—liver cancer	9.17e-06	5.04e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—IL6—liver cancer	8.98e-06	4.94e-05	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PIK3CA—liver cancer	8.82e-06	4.85e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—PIK3CA—liver cancer	8.57e-06	4.71e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GSTM1—liver cancer	8.54e-06	4.7e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PIK3CD—liver cancer	8.53e-06	4.69e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—ALB—liver cancer	8.42e-06	4.63e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TP53—liver cancer	8.29e-06	4.56e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—AKT1—liver cancer	8.29e-06	4.56e-05	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PIK3CA—liver cancer	8.21e-06	4.51e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—CYP1A1—liver cancer	8.1e-06	4.45e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—HRAS—liver cancer	7.93e-06	4.36e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—IL6—liver cancer	7.59e-06	4.17e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—MTHFR—liver cancer	7.55e-06	4.15e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PIK3CB—liver cancer	7.44e-06	4.09e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PPARA—liver cancer	7.41e-06	4.07e-05	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—AKT1—liver cancer	7.2e-06	3.96e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—AKT1—liver cancer	7e-06	3.85e-05	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—AKT1—liver cancer	6.7e-06	3.69e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PIK3CA—liver cancer	6.37e-06	3.5e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PIK3CG—liver cancer	6.34e-06	3.49e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PPARG—liver cancer	6.12e-06	3.37e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PIK3CD—liver cancer	5.58e-06	3.07e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—ALB—liver cancer	5.51e-06	3.03e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—AKT1—liver cancer	5.21e-06	2.86e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PIK3CB—liver cancer	4.86e-06	2.67e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PIK3CA—liver cancer	4.53e-06	2.49e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—AKT1—liver cancer	3.7e-06	2.04e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PIK3CA—liver cancer	2.96e-06	1.63e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—AKT1—liver cancer	2.42e-06	1.33e-05	CbGpPWpGaD
